EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antimicrobial resistance among agents of community-associated lower respiratory tract infection in the UK and Ireland: trends from 1999/2000 to 2018/2019

Rosy Reynolds, David Felmingham, Shazad Mushtaq iD, Carolyne Horner, Aiysha Chaudhry, Rachael Adkin, Michael Allen, Christopher Longshaw iD, Benjamin J Parcell, David M Livermore

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf252 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von Rosy Reynolds und 9 weiteren Autor:innen. Beteiligte Einrichtung: Population Health Sciences, University of Bristol, Bristol BS8 2PS, UK. Hauptthemen laut MEDLINE: Respiratory Tract Infections, Anti-Bacterial Agents, Community-Acquired Infections, Drug Resistance, Bacterial. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Society for Antimicrobial Chemotherapy.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The BSAC Respiratory Surveillance Programme examined resistance trends among Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired lower respiratory tract infection (CA-LRTI).

Methods

Quotas of isolates were sought per collecting site from 1999/00 to 2018/19; an annual October start date captured winter infection peaks within single years. MIC testing was by BSAC agar dilution. β-Lactamase detection with nitrocefin and pneumococcal serotyping by classical methods or WGS.

Results

Resistances were uncommon, except that β-lactamases occurred in c. 20% of H. influenzae from 2012/13 following earlier rises, and in >90% of M. catarrhalis throughout. Only 0.11% (12/10881) of S. pneumoniae were fully resistant to penicillin; co-amoxiclav inhibited 97.8% of 13526 H. influenzae and >99.9% of 6309 M. catarrhalis isolates. Cefotaxime inhibited >99% of all isolates at breakpoint, as did relevant fluoroquinolones in the fewer years tested. Tetracycline inhibited >98% of H. influenzae and M. catarrhalis and 85% of S. pneumoniae. Significant shifts were: (i) fluctuating resistances to tetracyclines, macrolides and penicillin in pneumococci, reflecting serotype replacements; (ii) expansion, from 2012/13, in the proportion of H. influenzae with β-lactamase-independent amoxicillin/co-amoxiclav resistance; and (iii) increasing high-level amoxicillin resistance (MIC > 64 mg/L) among β-lactamase-positive H. influenzae. MIC differentials were seen for cephalosporins between β-lactamase-positive and β-lactamase-negative M. catarrhalis, greatest (512-fold) for ceftaroline.

Conclusions

CA-LRTI remains eminently treatable, yet shifts are occurring in the serotypes of S. pneumoniae most associated with resistance and in the nature of amoxicillin resistance in H. influenzae. β-Lactamase-related cephalosporin MIC differentials for M. catarrhalis are striking but their clinical significance remains uncertain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Respiratory Tract InfectionsAnti-Bacterial AgentsCommunity-Acquired InfectionsDrug Resistance, BacterialHumansIrelandHaemophilus influenzaeMicrobial Sensitivity TestsUnited KingdomStreptococcus pneumoniaeMoraxella catarrhalisbeta-LactamasesAdultMiddle AgedInfantChild, PreschoolAgedChildAdolescentMaleYoung AdultFemale

Substanzen

Anti-Bacterial Agentsbeta-Lactamases

Autor:innen und Institutionen

  • Population Health Sciences, University of Bristol, Bristol BS8 2PS, UK.
  • British Society for Antimicrobial Chemotherapy, 53 Regent Place, Birmingham B1 3NJ, UK.
  • Hammerfest, Arrow Lane, Hartley Wintney RG27 8LR, UK.
  • Antimicrobial Resistance and Healthcare Associated Infections Reference Unit, UK Health Security Agency, Colindale, London NW9 5EQ, UK.
  • Medical Affairs, MSD (UK) Limited, 120 Moorgate, London EC2M 6UR, UK.
  • Scientific Affairs, Shionogi B.V., Fifty Paddington, 50 Eastbourne Terrace, Paddington W2 6LG, UK.

ORCID-Profile: Shazad Mushtaq, Christopher Longshaw

Förderung

  • British Society for Antimicrobial Chemotherapy

Zitieren

APA

Reynolds, R., Felmingham, D., Mushtaq, S., Horner, C., Chaudhry, A., Adkin, R., Allen, M., Longshaw, C., Parcell, B. J., & Livermore, D. M. (2025). Antimicrobial resistance among agents of community-associated lower respiratory tract infection in the UK and Ireland: trends from 1999/2000 to 2018/2019. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf252

Vancouver

Reynolds R, Felmingham D, Mushtaq S, Horner C, Chaudhry A, Adkin R, et al. Antimicrobial resistance among agents of community-associated lower respiratory tract infection in the UK and Ireland: trends from 1999/2000 to 2018/2019. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf252

BibTeX
@article{Reynolds2025,
  author = {Reynolds, Rosy and Felmingham, David and Mushtaq, Shazad and Horner, Carolyne and Chaudhry, Aiysha and Adkin, Rachael and Allen, Michael and Longshaw, Christopher and Parcell, Benjamin J and Livermore, David M},
  title = {Antimicrobial resistance among agents of community-associated lower respiratory tract infection in the UK and Ireland: trends from 1999/2000 to 2018/2019},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf252}
}
Kostenlos starten →